Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome b-245, beta polypeptide | Starlite/ChEMBL | References |
Homo sapiens | NADPH oxidase, EF-hand calcium binding domain 5 | Starlite/ChEMBL | References |
Homo sapiens | NADPH oxidase 4 | Starlite/ChEMBL | References |
Homo sapiens | NADPH oxidase 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | Blistered cuticle protein 3 | Get druggable targets OG5_127219 | All targets in OG5_127219 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_127219 | All targets in OG5_127219 |
Loa Loa (eye worm) | blistered cuticle protein 3 | Get druggable targets OG5_127219 | All targets in OG5_127219 |
Onchocerca volvulus | Dual oxidase homolog | Get druggable targets OG5_127219 | All targets in OG5_127219 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Blistered cuticle protein 3 | NADPH oxidase, EF-hand calcium binding domain 5 | 737 aa | 730 aa | 25.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.4884 | 0.4884 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0027 | 0 | 0.5 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0038 | 0.0519 | 0.0519 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0041 | 0.0626 | 0.5 |
Mycobacterium ulcerans | dehydrogenase | 0.0027 | 0 | 0.5 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0041 | 0.0626 | 0.5 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0027 | 0 | 0.5 |
Schistosoma mansoni | alpha-glucosidase | 0.0158 | 0.6014 | 1 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0041 | 0.0626 | 1 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0027 | 0 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0041 | 0.0626 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0027 | 0 | 0.5 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0183 | 0.7189 | 1 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0133 | 0.4884 | 0.8121 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0133 | 0.4884 | 0.6794 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0027 | 0 | 0.5 |
Trypanosoma brucei | ferric reductase transmembrane protein, putative | 0.0151 | 0.571 | 1 |
Trypanosoma cruzi | ferric reductase transmembrane protein, putative | 0.0151 | 0.571 | 1 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0183 | 0.7189 | 0.7189 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0027 | 0 | 0.5 |
Onchocerca volvulus | 0.0144 | 0.5403 | 0.278 | |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0041 | 0.0626 | 0.0626 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0133 | 0.4884 | 0.6794 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0183 | 0.7189 | 1 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0041 | 0.0626 | 0.0626 |
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0041 | 0.0626 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0027 | 0 | 0.5 |
Trypanosoma cruzi | ferric reductase transmembrane protein, putative | 0.0151 | 0.571 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0041 | 0.0626 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.4884 | 0.4884 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0027 | 0 | 0.5 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0027 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0027 | 0 | 0.5 |
Brugia malayi | SWIRM domain containing protein | 0.0144 | 0.5403 | 0.5403 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0027 | 0 | 0.5 |
Leishmania major | ferric reductase, putative | 0.0151 | 0.571 | 1 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0183 | 0.7189 | 0.7189 |
Schistosoma mansoni | alpha glucosidase | 0.0041 | 0.0626 | 0.1041 |
Mycobacterium ulcerans | monoamine oxidase | 0.0027 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0041 | 0.0626 | 0.1096 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0041 | 0.0626 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0041 | 0.0626 | 0.1096 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0741 | 1 |
Schistosoma mansoni | alpha-glucosidase | 0.0158 | 0.6014 | 1 |
Mycobacterium ulcerans | oxidoreductase | 0.0027 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0093 | 0.3044 | 0.3044 |
Echinococcus granulosus | neutral alpha glucosidase AB | 0.0041 | 0.0626 | 0.0871 |
Treponema pallidum | hypothetical protein | 0.0043 | 0.0741 | 0.5 |
Onchocerca volvulus | Dual oxidase homolog | 0.0244 | 1 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0027 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0144 | 0.5403 | 0.5403 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0183 | 0.7189 | 1 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0041 | 0.0626 | 0.1096 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0041 | 0.0626 | 0.5 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0027 | 0 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0041 | 0.0626 | 0.5 |
Echinococcus multilocularis | neutral alpha glucosidase AB | 0.0041 | 0.0626 | 0.0871 |
Loa Loa (eye worm) | blistered cuticle protein 3 | 0.0244 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0519 | 0.0519 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0041 | 0.0626 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0027 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (ADMET) | > 25 uM | Inhibition of human recombinant CYP1A2 assessed as inhibition of fluorescent metabolite formation | ChEMBL. | 22041175 |
IC50 (ADMET) | > 25 uM | Inhibition of human recombinant CYP2C9 by mass spectrophotometry | ChEMBL. | 22041175 |
IC50 (ADMET) | > 25 uM | Inhibition of human recombinant CYP2C19 by mass spectrophotometry | ChEMBL. | 22041175 |
IC50 (ADMET) | > 25 uM | Inhibition of human recombinant CYP2D6 by mass spectrophotometry | ChEMBL. | 22041175 |
IC50 (ADMET) | > 25 uM | Inhibition of human recombinant CYP3A4 by mass spectrophotometry | ChEMBL. | 22041175 |
Inhibition | = 8.7 % | Inhibition of hERG at 1 uM by patch clamp assay | ChEMBL. | 22041175 |
Inhibition (functional) | = 12 % | Antifibrotic activity in C57BL/6 mouse pulmonary fibrosis curative model assessed as reduction in bleomycin-induced collagen deposition at 100 mg/kg, po qd administered 10 days post challenge for 25 days measured on day 25 by SIRCOL assay | ChEMBL. | 22041175 |
Inhibition (functional) | = 64 % | Antifibrotic activity in C57BL/6 mouse pulmonary fibrosis curative model assessed as reduction in bleomycin-induced collagen deposition at 10 mg/kg, po qd administered 10 days post challenge for 25 days measured on day 25 by SIRCOL assay | ChEMBL. | 22041175 |
Ki (functional) | = 72 nM | Antagonist activity at human NOX4 expressed in CHO cell membrane coexpressing tetracylin repressor assessed as inhibition of ROS production after 20 mins by cell-free amplex red assay | ChEMBL. | 22041175 |
Ki (functional) | = 101 nM | Antagonist activity at human NOX1 expressed in CHO cell membrane coexpressing tetracylin repressor assessed as inhibition of ROS production after 20 mins by cell-free amplex red assay | ChEMBL. | 22041175 |
Ki (functional) | = 414 nM | Antagonist activity at human NOX5 assessed as inhibition of ROS production after 20 mins by cell-free amplex red assay | ChEMBL. | 22041175 |
Ki (functional) | = 1340 nM | Antagonist activity at human NOX2 in human polymorphonuclear cell membrane assessed as inhibition of ROS production after 20 mins by cell-free amplex red assay | ChEMBL. | 22041175 |
Ki (binding) | > 30000 nM | Inhibition of xanthine oxidase assessed as inhibition of ROS production after 20 mins by cell-free amplex red assay | ChEMBL. | 22041175 |
Papp (ADMET) | = 42.2 10'-6 cm/s | Apparent permeability across human Caco2 cells at 10 uM after 2 hrs | ChEMBL. | 22041175 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.